Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025
Authors | |
---|---|
Year of publication | 2025 |
Type | Article in Periodical |
Magazine / Source | Endoscopy |
MU Faculty or unit | |
Citation | |
web | https://www.esge.com/management-of-epithelial-precancerous-conditions-and-early-neoplasia-of-the-stomach-maps-iii-esge-ehmsg-esp-guideline-update-2025 |
Doi | http://dx.doi.org/10.1055/a-2529-5025 |
Keywords | early neoplasia of the stomach; epithelial precancerous conditions |
Description | At a population level, the European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter and Microbiota Study Group (EHMSG), and the European Society of Pathology (ESP) suggest endoscopic screening for gastric cancer (and precancerous conditions) in high-risk regions (age-standardized rate [ASR] > 20 per 100 000 person-years) every 2 to 3 years or, if cost–effectiveness has been proven, in intermediate risk regions (ASR 10–20 per 100 000 person-years) every 5 years, but not in low-risk regions (ASR < 10). ESGE/EHMSG/ESP recommend that irrespective of country of origin, individual gastric risk assessment and stratification of precancerous conditions is recommended for first-time gastroscopy. ESGE/EHMSG/ESP suggest that gastric cancer screening or surveillance in asymptomatic individuals over 80 should be discontinued or not started, and that patients’ comorbidities should be considered when treatment of superficial lesions is planned. |